A physician-scientist, inventor, and entrepreneur will deliver a state-of-the-art lecture titled “The Future of Health and Medicine: Where Can Technology Take Us?” on Saturday, November 6.
Daniel Kraft, MD, has served as the Chair for Medicine and Neuroscience at Singularity University since its inception in 2008. Singularity University describes itself as a global community using exponential technologies to tackle the world's biggest challenges. In 2011, Dr. Kraft founded the Exponential Medicine Program there, which explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.
Dr. Kraft currently chairs the XPRIZE Pandemic Alliance Task Force, a
The terms used in the patient-facing side of nephrology are changing, in sometimes controversial ways. A clinical practice session on this topic will feature the Celeste Castillo Lee Memorial Lectureship, “Make It Plain: The Patient Perspective on CKD Terminology,” on Saturday, November 6.
The speaker will be Glenda V. Roberts, a long-term kidney patient who is director of external relations and patient engagement at the Center for Dialysis Innovation and the Kidney Research Institute at the University of Washington. Prior to joining the university, Ms. Roberts spent 35 years as an information technology executive.
David R. Williams, PhD, MPH, will present a state-of-the-art lecture on “Social Inequities in Health: How Can We Effectively Reduce Them?” on Friday, November 5.
Dr. Williams is the Florence and Laura Norman Professor of Public Health and Chair of the Department of Social and Behavioral Sciences at the Harvard T.H. Chan School of Public Health. He is also a professor of African and African American Studies at Harvard University.
Dr. Williams has played a national leadership role in raising awareness of the problem of health inequities and identifying interventions to address them. His work
ASN will introduce a new lifetime achievement award, the ASN Trailblazer Award, on Friday, November 5. The inaugural recipient will be Barbara T. Murphy, MB BAO BCh, who lost her battle with glioblastoma on June 30, 2021. At the time of her death, Dr. Murphy was ASN president-elect.
The new award honors leaders who strengthen the foundation of nephrology while advancing the field through innovation, creativity, inspiration, and tenacity.
“ASN will present the award to Barbara T. Murphy [posthumously] in recognition of her extraordinary contributions to patient care, research, and education as well as
A scientist who shared a Nobel Prize for her key discoveries in chromosome replication will discuss the implications for kidney health in a state-of-the-art lecture on Sunday, November 7.
Carol W. Greider, PhD, will speak on “Telomeres and Telomerase in Health and Kidney Disease.” Dr. Greider is a distinguished professor of Molecular, Cell, and Developmental Biology at the University of California Santa Cruz, as well as a university professor at Johns Hopkins University.
Dr. Greider shared the 2009 Nobel Prize in Physiology or Medicine with Dr. Elizabeth Blackburn and Dr. Jack Szostak for their work on
A long-term researcher in the subject will provide “Novel Insight into the Contribution of Phosphate to Mineral and Bone Defects in CKD” in the Jack W. Coburn, MD, Endowed Lectureship on Saturday, November 6.
The speaker will be Hartmut H. Malluche, MD, who is the Robert G. Luke chair in nephrology and chief of the Division of Nephrology, Bone & Mineral Metabolism at the University of Kentucky in Lexington. Prior to his current role, he was associate professor of medicine in the Division of Nephrology at the University of Southern California Medical Center in Los Angeles.
Prominent investigator Melissa H. Little, PhD, will be presented the Homer W. Smith Award on Sunday, November 7. This award recognizes outstanding contributions to understanding how kidneys function in normal and diseased states.
Dr. Little will speak on ‘‘From Understanding Kidney Development to Rebuilding a Kidney: Progress and Challenges.”
She is the theme director of cell biology and senior principal research fellow at the Murdoch Children's Research Institute as well as professor of medicine, dentistry, and health sciences at the University of Melbourne in Australia. She is also program leader of Stem Cells Australia.
The title of the Burton D. Rose, MD, Endowed Lectureship will be “Evolution of Renal Pathophysiology: Key Observations over Five Decades.”
The speaker will be Helmut G. Rennke, MD, who is professor of pathology at Harvard Medical School and director of the renal pathology and electron microscopy laboratory at Brigham and Women's Hospital in Boston. The lecture is scheduled for Saturday, November 6.
Dr. Rennke's research in renal pathology is aided by his laboratory's workload of some 1500 cases per year. Most renal biopsies and many of the nephrectomy specimens examined require immunofluorescence and electron microscopy
The Robert W. Schrier, MD, Endowed Lectureship will focus on “Oxygen Biology and Metabolism in the Kidneys” on Friday, November 5.
The speaker will be Masaomi Nangaku, MD, PhD, who is vice dean, professor, and head of the Division of Nephrology and Endocrinology at The University of Tokyo Graduate School of Medicine.
Dr. Nangaku's scientific achievements extend to both basic studies of oxygen biology and clinical trials in anemia in chronic kidney disease and diabetic kidney disease. His research efforts include chronic hypoxia and oxidative stress as a common pathway to kidney failure, diabetic kidney disease,
A leading researcher in bioinformatics will deliver the Barry M. Brenner, MD, Endowed Lectureship on “Applied Precision Medicine in Glomerular Diseases” on Thursday, November 4.
The speaker will be Matthias Kretzler, MD, who is the Warner-Lambert/Parke-Davis professor of internal medicine, nephrology, and computational bioinformatics at the University of Michigan Medical School in Ann Arbor.
Dr. Kretzler's research is aimed at defining chronic kidney disease in mechanistic terms and using this knowledge for targeted therapeutic interventions. In pursuit of this goal, his research team has developed a translational research pipeline centered on integrated systems-biology analysis of kidney disease.